Ashish Mandelia - Net Worth and Insider Trading
Ashish Mandelia Net Worth
The estimated net worth of Ashish Mandelia is at least $68,584 dollars as of 2024-04-29. Ashish Mandelia is the VP, Chief Accounting Officer of Mersana Therapeutics Inc and owns about 23,328 shares of Mersana Therapeutics Inc (MRSN) stock worth over $68,584. Details can be seen in Ashish Mandelia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ashish Mandelia has not made any transactions after 2024-01-16 and currently still holds the listed stock(s).
Transaction Summary of Ashish Mandelia
Ashish Mandelia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ashish Mandelia owns 1 companies in total, including Mersana Therapeutics Inc (MRSN) .
Click here to see the complete history of Ashish Mandelia’s form 4 insider trades.
Insider Ownership Summary of Ashish Mandelia
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRSN | Mersana Therapeutics Inc | 2024-01-16 | VP & Controller |
Ashish Mandelia Latest Holdings Summary
Ashish Mandelia currently owns a total of 1 stock. Ashish Mandelia owns 23,328 shares of Mersana Therapeutics Inc (MRSN) as of January 16, 2024, with a value of $68,584.
Latest Holdings of Ashish Mandelia
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRSN | Mersana Therapeutics Inc | 2024-01-16 | 23,328 | 2.94 | 68,584 |
Holding Weightings of Ashish Mandelia
Ashish Mandelia Form 4 Trading Tracker
According to the SEC Form 4 filings, Ashish Mandelia has made a total of 6 transactions in Mersana Therapeutics Inc (MRSN) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Mersana Therapeutics Inc is the sale of 5,025 shares on January 16, 2024, which brought Ashish Mandelia around $13,618.
Insider Trading History of Ashish Mandelia
- 1
Ashish Mandelia Trading Performance
GuruFocus tracks the stock performance after each of Ashish Mandelia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ashish Mandelia is -20.43%. GuruFocus also compares Ashish Mandelia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ashish Mandelia within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ashish Mandelia's insider trading performs compared to the benchmark.
Performance of Ashish Mandelia
Average Return
-41.97%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.8 | -20.43 | 13.59 | -41.97 | -55.57 | -48 |
| Relative Return to S&P 500(%) | -18.51 | -28.9 | -6.79 | -80.59 | -66.07 | -60.81 |
Ashish Mandelia Ownership Network
Ownership Network List of Ashish Mandelia
Ownership Network Relation of Ashish Mandelia
Ashish Mandelia Owned Company Details
What does Mersana Therapeutics Inc do?
Who are the key executives at Mersana Therapeutics Inc?
Ashish Mandelia is the VP & Controller of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include Chief Legal Officer Alejandra Carvajal , SVP & Chief Development Officer Mohan Bala , and Chief Manufacturing Officer Tushar Misra .
Mersana Therapeutics Inc (MRSN) Insider Trades Summary
Over the past 18 months, Ashish Mandelia made 2 insider transaction in Mersana Therapeutics Inc (MRSN) with a net sale of 8,600. Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 9,107 shares made by Alejandra Carvajal , a net sale of 5,723 shares made by Tushar Misra , and a net sale of 46,745 shares made by Anna Protopapas .
In summary, during the past 3 months, insiders sold 0 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,354 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114,354 shares.
Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mersana Therapeutics Inc Insider Transactions
Ashish Mandelia Mailing Address
Above is the net worth, insider trading, and ownership report for Ashish Mandelia. You might contact Ashish Mandelia via mailing address: 840 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
